Long-Term Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator System

Affiliations

¹ Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA. Electronic address: jonathan.steinberg@heart.rochester.edu.
² Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.

Free article

Editorial

Jonathan S Steinberg et al. J Am Coll Cardiol. 2023.

Free article

. 2023 Aug 1;82(5):398-400.

doi: 10.1016/j.jacc.2023.05.037.

¹ Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA. Electronic address: jonathan.steinberg@heart.rochester.edu.
² Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.

No abstract available

Keywords: cardiac arrhythmias; heart failure; implantable defibrillators; ventricular fibrillation; ventricular tachycardia.

Conflict of interest statement

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
Gold MR, El-Chami MF, Burke MC, Upadhyay GA, Niebauer MJ, Prutkin JM, Herre JM, Kutalek S, Dinerman JL, Knight BP, Leigh J, Lucas L, Carter N, Brisben AJ, Aasbo JD, Weiss R; S-ICD System Post Approval Study Investigators. Gold MR, et al. J Am Coll Cardiol. 2023 Aug 1;82(5):383-397. doi: 10.1016/j.jacc.2023.05.034. J Am Coll Cardiol. 2023. PMID: 37495274